Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

Bristol-Myers Squibb Company announced a significant update in their Sjögren’s Syndrome study. The Phase 3 study tests ...

Remegen Co. Ltd.’s telitacicept (RC-18) met the primary endpoint in a phase III trial for treating primary Sjögren's syndrome (pSS), and the company plans to submit a BLA to China’s National Medical ...

Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her ...

Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her ...

World No. 1 Jannik Sinner has yet to drop a set at the Cincinnati Open heading into the quarterfinals. Sinner will face Felix ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 3 study titled ‘A Phase 3 Randomized, ...

The drug met its primary endpoints in a Chinese trial, while a Phase III trial in Sjögren's syndrome is currently underway in ...

By HOWARD FENDRICH AP Tennis Writer Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her first Grand Slam competition in two years.

The Chicago Stars have named former Norway women's national team coach Martin Sjögren as the National Women's Soccer League club’s new head coach. Sjögren will join the Stars starting with the 2026 ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...